• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶活性和 ADRN/MES 分化状态在神经母细胞瘤肿瘤生物学中的相互影响。

Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.

机构信息

Department of Microbiology & Immunology, W. R. Hearst Microbiology Research Center, Weill Cornell Medicine, New York, NY, USA.

Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.

出版信息

Commun Biol. 2021 Nov 19;4(1):1315. doi: 10.1038/s42003-021-02821-8.

DOI:10.1038/s42003-021-02821-8
PMID:34799676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8604896/
Abstract

Telomere maintenance and tumor cell differentiation have been separately implicated in neuroblastoma malignancy. Their mechanistic connection is unclear. We analyzed neuroblastoma cell lines and morphologic subclones representing the adrenergic (ADRN) and mesenchymal (MES) differentiation states and uncovered sharp differences in their telomere protein and telomerase activity levels. Pharmacologic conversion of ADRN into MES cells elicited consistent and robust changes in the expression of telomere-related proteins. Conversely, stringent down-regulation of telomerase activity triggers the differentiation of ADRN into MES cells, which was reversible upon telomerase up-regulation. Interestingly, the MES differentiation state is associated with elevated levels of innate immunity factors, including key components of the DNA-sensing pathway. Accordingly, MES but not ADRN cells can mount a robust response to viral infections in vitro. A gene expression signature based on telomere and cell lineage-related factors can cluster neuroblastoma tumor samples into predominantly ADRN or MES-like groups, with distinct clinical outcomes. Our findings establish a strong mechanistic connection between telomere and differentiation and suggest that manipulating telomeres may suppress malignancy not only by limiting the tumor growth potential but also by inducing tumor cell differentiation and altering its immunogenicity.

摘要

端粒维持和肿瘤细胞分化分别与神经母细胞瘤的恶性程度有关。它们之间的机制联系尚不清楚。我们分析了神经母细胞瘤细胞系和代表肾上腺素能 (ADRN) 和间充质 (MES) 分化状态的形态亚克隆,发现它们的端粒蛋白和端粒酶活性水平存在明显差异。ADRN 向 MES 细胞的药理转化引起了与端粒相关蛋白表达的一致和强烈变化。相反,严格下调端粒酶活性会触发 ADRN 向 MES 细胞的分化,而端粒酶上调可使其逆转。有趣的是,MES 分化状态与先天免疫因子水平升高有关,包括 DNA 感应途径的关键组成部分。因此,MES 而非 ADRN 细胞可以在体外对病毒感染产生强烈反应。基于端粒和细胞谱系相关因素的基因表达特征可以将神经母细胞瘤肿瘤样本聚类为主要 ADRN 或 MES 样组,具有不同的临床结局。我们的发现确立了端粒与分化之间的紧密机制联系,并表明通过限制肿瘤生长潜力以及诱导肿瘤细胞分化和改变其免疫原性来操纵端粒可能不仅可以抑制恶性程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/f055e7c07bfe/42003_2021_2821_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/1349c62038bc/42003_2021_2821_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/a63e6bf446c4/42003_2021_2821_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/4f37624de009/42003_2021_2821_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/22361415dec1/42003_2021_2821_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/254649b2cba3/42003_2021_2821_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/f055e7c07bfe/42003_2021_2821_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/1349c62038bc/42003_2021_2821_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/a63e6bf446c4/42003_2021_2821_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/4f37624de009/42003_2021_2821_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/22361415dec1/42003_2021_2821_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/254649b2cba3/42003_2021_2821_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/8604896/f055e7c07bfe/42003_2021_2821_Fig6_HTML.jpg

相似文献

1
Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.端粒酶活性和 ADRN/MES 分化状态在神经母细胞瘤肿瘤生物学中的相互影响。
Commun Biol. 2021 Nov 19;4(1):1315. doi: 10.1038/s42003-021-02821-8.
2
Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.将端粒维持和调控与神经母细胞瘤肿瘤细胞的发育起源和分化状态联系起来。
J Hematol Oncol. 2022 Aug 27;15(1):117. doi: 10.1186/s13045-022-01337-w.
3
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.根据间充质和肾上腺素能特征,描述高危神经母细胞瘤患者 T 细胞炎症与结局的关系。
Cancer Res Commun. 2024 Aug 1;4(8):2255-2266. doi: 10.1158/2767-9764.CRC-24-0214.
4
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets.神经母细胞瘤表面组的谱系依赖性定义了肿瘤细胞状态依赖性和非依赖性免疫治疗靶点。
bioRxiv. 2024 Jul 2:2024.06.27.600865. doi: 10.1101/2024.06.27.600865.
5
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.无肾上腺素能和间充质特征可在无细胞 DNA 中识别,并与神经母细胞瘤患儿的转移性疾病负担相关。
Pediatr Blood Cancer. 2024 Jan;71(1):e30735. doi: 10.1002/pbc.30735. Epub 2023 Oct 20.
6
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.在无细胞DNA中可识别出肾上腺素能和间充质特征,且这些特征与神经母细胞瘤患儿的转移性疾病负担相关。
bioRxiv. 2023 Sep 1:2023.08.30.554943. doi: 10.1101/2023.08.30.554943.
7
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.肿瘤坏死因子-α与表皮生长因子联合诱导SH-SY5Y神经母细胞瘤细胞发生肾上腺素能向间充质转分化。
Cancer Sci. 2021 Feb;112(2):715-724. doi: 10.1111/cas.14760. Epub 2020 Dec 21.
8
Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells.神经母细胞瘤向间充质状态的转变可能表现为 GD2 高表达,并获得对 NK 细胞的免疫逃逸。
Front Immunol. 2024 Apr 26;15:1382931. doi: 10.3389/fimmu.2024.1382931. eCollection 2024.
9
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.间质型神经母细胞瘤细胞逃避 ALK 抑制剂。
Cancer Res. 2022 Feb 1;82(3):484-496. doi: 10.1158/0008-5472.CAN-21-1621. Epub 2021 Dec 1.
10
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.T细胞炎症对富含肾上腺素能特征的高危神经母细胞瘤患者的生存具有预后意义。
bioRxiv. 2023 Jun 28:2023.06.26.546541. doi: 10.1101/2023.06.26.546541.

引用本文的文献

1
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.神经母细胞瘤诊断、治疗与研究的新趋势
Mol Neurobiol. 2025 May;62(5):6423-6466. doi: 10.1007/s12035-024-04680-w. Epub 2025 Jan 13.
2
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy.高危神经母细胞瘤:基于抗体的细胞免疫疗法面临的挑战与机遇
J Clin Med. 2024 Aug 13;13(16):4765. doi: 10.3390/jcm13164765.
3
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity.

本文引用的文献

1
Epigenetic state determines inflammatory sensing in neuroblastoma.表观遗传学状态决定神经母细胞瘤中的炎症感应。
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6). doi: 10.1073/pnas.2102358119.
2
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel.间充质神经母细胞瘤细胞无法被当前的mRNA标志物检测板检测到:一种特定的神经母细胞瘤间充质微小残留病检测板的开发。
JCO Precis Oncol. 2019 Oct 3;3. doi: 10.1200/PO.18.00413. eCollection 2019.
3
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome.
枪中两弹:通过靶向肾上腺素能-间充质可塑性,将免疫疗法与化疗相结合以战胜神经母细胞瘤。
Front Immunol. 2023 Oct 2;14:1268645. doi: 10.3389/fimmu.2023.1268645. eCollection 2023.
4
Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.将端粒维持和调控与神经母细胞瘤肿瘤细胞的发育起源和分化状态联系起来。
J Hematol Oncol. 2022 Aug 27;15(1):117. doi: 10.1186/s13045-022-01337-w.
儿童神经母细胞瘤端粒的替代延长:从基因组到蛋白质组。
Nat Commun. 2021 Feb 24;12(1):1269. doi: 10.1038/s41467-021-21247-8.
4
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.肿瘤与正常单细胞 mRNA 比较揭示了泛神经母细胞瘤癌细胞。
Sci Adv. 2021 Feb 5;7(6). doi: 10.1126/sciadv.abd3311. Print 2021 Feb.
5
Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.单细胞描绘肾上腺神经母细胞瘤的恶性表型和发育轨迹。
Cancer Cell. 2020 Nov 9;38(5):716-733.e6. doi: 10.1016/j.ccell.2020.08.014. Epub 2020 Sep 17.
6
Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase.功能失调的端粒通过环鸟苷酸-腺苷酸合酶触发细胞衰老。
J Biol Chem. 2020 Aug 7;295(32):11144-11160. doi: 10.1074/jbc.RA120.012962. Epub 2020 Jun 15.
7
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.针对高危神经母细胞瘤中端粒维持机制的新型治疗策略。
J Exp Clin Cancer Res. 2020 May 6;39(1):78. doi: 10.1186/s13046-020-01582-2.
8
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.端粒维持机制定义高危神经母细胞瘤的临床转归。
Cancer Res. 2020 Jun 15;80(12):2663-2675. doi: 10.1158/0008-5472.CAN-19-3068. Epub 2020 Apr 14.
9
Epigenetic Targeting of -Associated Gene Expression Signature in Human Neuroblastoma with Overexpression.- 基因表达特征的表观遗传靶向与人类神经母细胞瘤中的过表达。
Cancer Res. 2020 Mar 1;80(5):1024-1035. doi: 10.1158/0008-5472.CAN-19-2560. Epub 2020 Jan 3.
10
ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.ATR 缺失会导致端粒功能障碍,并在人类细胞永生化过程中需要诱导端粒的替代延长。
EMBO J. 2019 Oct 1;38(19):e96659. doi: 10.15252/embj.201796659. Epub 2019 Aug 27.